These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37943878)

  • 1. Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth.
    He A; Tian S; Kopper O; Horan DJ; Chen P; Bronson RT; Sheng R; Wu H; Sui L; Zhou K; Tao L; Wu Q; Huang Y; Shen Z; Han S; Chen X; Chen H; He X; Robling AG; Jin R; Clevers H; Xiang D; Li Z; Dong M
    PLoS Biol; 2023 Nov; 21(11):e3002353. PubMed ID: 37943878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frizzled receptors (FZDs) in Wnt signaling: potential therapeutic targets for human cancers.
    Liu HY; Sun XJ; Xiu SY; Zhang XY; Wang ZQ; Gu YL; Yi CX; Liu JY; Dai YS; Yuan X; Liao HP; Liu ZM; Pang XC; Li TC
    Acta Pharmacol Sin; 2024 Aug; 45(8):1556-1570. PubMed ID: 38632318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for recognition of frizzled proteins by
    Chen P; Tao L; Wang T; Zhang J; He A; Lam KH; Liu Z; He X; Perry K; Dong M; Jin R
    Science; 2018 May; 360(6389):664-669. PubMed ID: 29748286
    [No Abstract]   [Full Text] [Related]  

  • 4. WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth.
    Matsuda Y; Schlange T; Oakeley EJ; Boulay A; Hynes NE
    Breast Cancer Res; 2009; 11(3):R32. PubMed ID: 19473496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into Wnt signaling inhibition by Clostridium difficile toxin B.
    Chen P; Tao L; Liu Z; Dong M; Jin R
    FEBS J; 2019 Mar; 286(5):874-881. PubMed ID: 30347517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
    Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM
    J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.
    Tao L; Zhang J; Meraner P; Tovaglieri A; Wu X; Gerhard R; Zhang X; Stallcup WB; Miao J; He X; Hurdle JG; Breault DT; Brass AL; Dong M
    Nature; 2016 Oct; 538(7625):350-355. PubMed ID: 27680706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists.
    Yin P; Wang W; Zhang Z; Bai Y; Gao J; Zhao C
    Cancer Sci; 2018 Nov; 109(11):3368-3375. PubMed ID: 30137666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.
    Pan Z; Zhang Y; Luo J; Li D; Zhou Y; He L; Yang Q; Dong M; Tao L
    PLoS Pathog; 2021 Jan; 17(1):e1009197. PubMed ID: 33507919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frizzled Receptors in Tumors, Focusing on Signaling, Roles, Modulation Mechanisms, and Targeted Therapies.
    Sun Y; Wang W; Zhao C
    Oncol Res; 2021 Mar; 28(6):661-674. PubMed ID: 32998794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paracrine Wnt signaling both promotes and inhibits human breast tumor growth.
    Green JL; La J; Yum KW; Desai P; Rodewald LW; Zhang X; Leblanc M; Nusse R; Lewis MT; Wahl GM
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6991-6. PubMed ID: 23559372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
    Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
    FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
    Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
    Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
    [No Abstract]   [Full Text] [Related]  

  • 17. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
    Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
    J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
    Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
    Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Flanagan DJ; Barker N; Costanzo NSD; Mason EA; Gurney A; Meniel VS; Koushyar S; Austin CR; Ernst M; Pearson HB; Boussioutas A; Clevers H; Phesse TJ; Vincan E
    Cancer Res; 2019 Mar; 79(5):970-981. PubMed ID: 30622113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists.
    Lv C; Li F; Li X; Tian Y; Zhang Y; Sheng X; Song Y; Meng Q; Yuan S; Luan L; Andl T; Feng X; Jiao B; Xu M; Plikus MV; Dai X; Lengner C; Cui W; Ren F; Shuai J; Millar SE; Yu Z
    Nat Commun; 2017 Oct; 8(1):1036. PubMed ID: 29051494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.